OTURUM - 15 (SÖZEL BİLDİRİ): Colorectal Cancer and Associated Other Malignant Tumors Session-2 | Tarih/Date: 18.5.2025, 9:00 - 10:30 | Salon/Hall: Antalya 2
SB-117 Impact of Inflammatory Markers on Survival in Stage III Colorectal Cancer
Serhat Kircicegi, Kamil Erozkan, Recep Temel, Osman Bozbiyik, Cemil Caliskan, Mustafa Ali Korkut, Erhan Akgun
SB-118 Prognostic Impact of Pathologic Complete Response on Long-Term Survival in Locally Advanced Rectal Cancer Following Neoadjuvant Treatment
Berk Sertoz, Kamil Erozkan, Osman Bozbiyik, Cemil Caliskan, Mustafa Ali Korkut, Erhan Akgun
SB-119 Analysis of Prognostic Factors on Early and Late Mortality in Geriatric Colorectal Cancer Patients
Ezgi Tatlısu, Mehmet Baykan, Yusuf Sevim
SB-120 Prognostic Significance of CEA Levels in Rectal Cancer Patients
Kaan Sunter, Yiğit Ata Öztürk, Abdulkadeer Ateek, Cevad Sehade, Hamza Ba'arah, Ahmad Waddah Darvish, Ibrahim Mahroum, Muath Al Juneidi, Süleyman Utku Çelik, Mehmet Ali Koç, Cihangir Akyol
SB-121 The Role of Pressurized Intraperitoneal Aerosol Chemotherapy in Colorectal Peritoneal Carcinomatosis
Pırıltı Özcan, Özgül Düzgün
SB-122 Can Neoadjuvant Chemoradiotherapy Be Omitted in Ct2n+ And Ct3 Mid-Rectal Cancer: Protocol for a Prospective, Observational, Non-İnferiority Trial (CANO
Feza Karakayali, Çiğdem Arslan, Tayfun Bisgin, İlknur Erenler Bayraktar, Onur Bayraktar, Aras Emre Canda
SB-123 Retrospective Study on the Relationship Between Prognostic Factors of Colorectal Cancer and Tumor Markers
İlgiz Tüzken, Şevval Selin İlhan, Alper Eraslan, Melek İtek, Jouman Baroudi, Zouher Mokayed, Can Yahya Boztuğ, Süleyman Utku Çelik, Mehmet Ali Koç, Cihangir Akyol
SB-124 Incidence, Mortality and Survival of the Rectal Cancer: A Nationwide Population-based Study in Türkiye
Bengi Balcı, Çağla Sarıtürk, İsmail Tırnova, Feza Karakayalı, Şuayip Birinci
SB-125 Predictors of Postoperative Complications in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Retrospective Cohort Study
Semra Demirli Atici, Aras Emre Canda, Mustafa Cem Terzi

 

Kongremiz, Ethical MedTech tarafından onaylanmıştır.